Ontology highlight
ABSTRACT:
INSTRUMENT(S):
ORGANISM(S): Rattus Norvegicus (rat)
TISSUE(S): Cell Culture, Mesenchymal Stem Cell Of The Bone Marrow
DISEASE(S): Disease Free
SUBMITTER:
Pedro Silva
LAB HEAD: Pedro Leme Silva
PROVIDER: PXD027718 | Pride | 2026-02-09
REPOSITORIES: Pride
| Action | DRS | |||
|---|---|---|---|---|
| 20200617_02_Amostra16_01.sqt | Other | |||
| 20200617_02_Amostra16_01__1_.raw | Raw | |||
| 20200617_02_Amostra16_02.raw | Raw | |||
| 20200617_02_Amostra16_02.sqt | Other | |||
| 20200617_02_Amostra16_03.raw | Raw |
Items per page: 5 1 - 5 of 97 |

Santos Renata Trabach RT Braga Cássia Lisboa CL de Sá Freire Onofre Maria Eduarda ME da Silva Carla Medeiros CM de Novaes Rocha Nazareth N Veras Rodrigo Gonzaga RG de Souza Serra Sabrina Sodré SS Teixeira Douglas Esteves DE Dos Santos Alves Sarah Aparecida SA Miranda Beatriz Toja BT Pereira Miria Gomes MG Neves Celso Caruso CC de Oliveira Garcia Monique Ramos MR Takiya Christina Maeda CM Rocco Patricia Rieken Macêdo PRM Cruz Fernanda Ferreira FF Silva Pedro Leme PL
Stem cell research & therapy 20250829 1
<h4>Background</h4>During pulmonary arterial hypertension (PAH), cardiac cells develop a hypertrophic and apoptosis-resistant phenotype. Mesenchymal stromal cell (MSC) therapy has been shown to mitigate pulmonary vascular remodeling in PAH; however, successful application is limited by low potency and the need for a high number of MSCs. MSCs exposed to hypoxia release more extracellular vesicles (EV)s with different content than normoxia. We aimed to evaluate the proteomic profile and therapeuti ...[more]